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ABSTRACT
INCREASING READINESS TO CHANGE AMONG 
SMOKERS IN A PRIMARY CARE SETTING
Sheila F. Collicott 
Old Dominion University, 2000 
Director. Dr. Robin J. Lewis
This study compared the effectiveness of two brief interventions, direct advice and 
motivational interviewing, for increasing motivation to quit among male smokers in the 
pre-contemplation and contemplation stages of change who were primary care patients at 
an Eastern urban VA medical center. Contrary to expectations, participants receiving 
motivational interviews did not increase more in readiness to change, motivation, and 
actions to quit, than those receiving direct advice or a control conversation, nor did they 
smoke fewer cigarettes per day. As expected, contemplators reported more cutting down 
and quit attempts than pre-contemplators. Factors that may have limited the effectiveness 
of interventions are discussed.
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INTRODUCTION
Smoking is the main preventable cause of death and disease in the United States 
(U.S. Department of Health and Human Services [USDHHS 1, 1989). It accounts for more 
than 400,000 premature deaths each year (USDHHS, 1994), or 20% of all deaths 
(McGinnis & Foege, 1993). This exceeds the total deaths caused by alcohol, firearms, 
sexual behavior, motor vehicles, and illicit drugs combined. One-fourth o f American 
adults (48 million people) smoke (Centers for Disease Control [CDC|, 1994, 1996) and 
half of all those who do not quit will die of the effects of smoking (USDHHS, 1989).
Smoking also puts others at risk. Exposure to secondhand tobacco smoke accounts 
for about 53,000 deaths each year (Glantz & Parmley, 1991). Second-hand smoke has 
been causally linked to lung cancer (U.S. Environmental Protection Agency [EPA,| 1992) 
and to increased risk for cardiovascular disease (Wald & Ritchie, 1984; Wald et al., 1984; 
Glantz & Parmley, 1991, 1995.)
More than 70% of smokers say they want to quit, but few are actually able to do so 
(CDC, 1996). Each year about 35% are able to stop for at least one day (USDHHS, 1990), 
but less than 10% are able to maintain long-term abstinence (Fiore et al., 1990).
Traditional smoking cessation interventions target smokers who are committed to 
quitting soon (Prochaska, 19%). About 80% of smokers do not have immediate plans to 
quit, and traditional smoking cessation interventions are generally not helpful for them 
(Velicer, et al., 1995). Some interventions, such as those in which smokers feel
The American Psychological Association Publication Manual was the model for this 
dissertation.
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confronted, can actually decrease the likelihood of quitting (Miller, Benefield, &
Tonegan, 1993; Stott & Pill, 1990).
Smokers tend to visit their physicians more often than do non-smokers (Ockene, 
1987). Smoking cessation advice from a physician is associated with increased quitting 
(Gilpin, Pierce, Johnson & Bal, 1993; Law & Tang, 1995). Like other traditional 
interventions, physician advice is most helpful for smokers who are committed to quitting 
in the near future.
The process of changing smoking behavior is frequently seen as a continuum of 
increasing readiness to change that has been described as a series of five stages of change. 
Smokers' needs and interests vary with their stage of change (Prochaska, DiClemente, & 
Norcross, 1992). Motivational interviewing (MI) is a stage-matched intervention designed 
to increase motivation to change and is adaptable to a variety of settings, easily taught, 
inexpensive, and free of harmful effects (Miller & Rollnick, 1991). It was designed for 
use with drinkers (Miller, 1983, 1985) and has also been used with smokers (DiClemente, 
1991; Rollnick, Butler, & Stott, 1997).
This study compared MI to direct advice (DA) and to a control conversation (CC) for 
male primary care patients at a Veteran's Administration (VA) medical center. It was 
hypothesized that, among smokers who were not motivated to quit, those who received 
MI would increase more in readiness to quit than those who received DA or CC.
Smoking cessation is currendy being addressed with a great number and variety of 
interventions. Success rates for these interventions vary gready. Much of the variation can 
be attributed to differences among the interventions, the facilitators, and the methods used 
in smoking cessation studies.
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Major factors associated with higher rates of cessation success include smoking- 
related health concerns (Law & Tang, 1995), low nicotine dependence (Lam, Sze, Sacks, 
& Chalmers, 1987; USDHHS, 1988), receiving stop-smoking advice at the most recent 
physician visit (Gilpin et al., 1993; Manley, Epps, & Glynn, 1992; Tomar, Husten, & 
Manley, 19%), and being ready to quit, which includes high motivation to quit 
(Prochaska & DiClemente, 1983; Prochaska et al., 1992). Conversely, factors associated 
with failure to quit include not receiving advice at the most recent physician visit (Gilpin 
et al., 1993; Manley et al., 1992; Tomar et al., 19%), high nicotine dependence (Lam et 
al., 1987; USDHHS, 1988), and lack of readiness to quit (Prochaska et al., 1992). The 
quit rate in the general population of smokers, without intervention, has been estimated to 
be about 2% (Orleans, 1985).
Advice to quit, pharmacological interventions, and behavioral treatment are the most 
frequently used clinical interventions for smoking cessation. Each of these will be 
reviewed.
Advice to Quit
Advice to quit is direct, inexpensive, and one of the most frequently used smoking 
cessation interventions. Physicians are among the most frequent providers of such advice 
because they have ongoing contact with their patients who smoke. More than 70% of 
smokers report visiting a physician each year, but, unfortunately, only about half of them 
receive advice to quit from their physicians (Gilpin et al., 1993; Ockene, 1987; Tomar et 
al, 19%).
Physician advice is defined a single instance of a physician instructing a patient who 
smokes to quit It is often provided during a visit for routine care and typically involves
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4
telling the patient about the dangers of smoking and advising him or her to quit (Ockene 
et al., 1991). It may also include a description of techniques for quitting (Law and Tang, 
1995). The DA intervention in this study was designed to be similar to physician advice.
Studies of the effectiveness of physician advice indicate that it produces small but 
stable quit rates. Law and Tang (1995) found that patients who had been advised by their 
physicians to quit did so at a rate that was about 2% (1 % to 3%) greater than the quit rate 
in control groups. They reviewed 188 controlled trials of physician advice with six-month 
or longer follow-up measurements. Seventeen of the studies evaluated brief advice and 
encouragement delivered in single sessions by physicians to a total of 14,438 subjects.
The interventions normally took less than five minutes. Some included setting a quit date. 
Smoking status was validated bio-chemically in six o f the studies, which confirmed the 
overall results.
Many people quit smoking each year as a result of smoking cessation advice from 
their physicians. However, because they represent such a small percentage of smokers 
counseled, providing advice to quit can seem unrewarding to physicians and inhibit their 
motivation to intervene (Manley et al, 1992).
Physician advice is highly individual. Gilpin et al. (1993) found that only 43.2% of 
their sample received advice to quit at their last visit, while 72.1% reported being advised 
to quit at some time other than their last v isit Only advice at the most recent office visit 
was associated with making a quit attempt in the past year. When physicians are both 
trained in brief interventions and reminded to intervene with each patient, quit rates 
among their patients have increased as much as 15% (Manley et al, 1992).
Some smokers are more likely to be advised than others. Poor perceived health status
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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(Hymowitz, Jackson, Carter, & Eckholdt, 1996), being over 45 years old, or smoking 
more than 25 cigarettes per day (Tomar et al., 1996) are associated with receiving advice 
to quit. The relationship between race/ethnicity and physician advice is mixed. Hymowitz 
et al. (1996) report that race is a stronger predictor of receiving advice than either age or 
perceived health status and that whites are advised more frequently than African- 
Americans. Tomar et al. (19%) found no significant difference between whites and 
African-Americans in the frequency with which they were advised. However, both whites 
and African-Americans were significantly more likely to receive advice to quit than 
Hispanic smokers. It is noteworthy that racial differences occurred whether advice was 
given in the past year (Tomar et al., 19%) or any time in the past (Hymowitz et al., 19%).
Providing advice does not ensure that it will be heeded. Physician advice often elicits 
negative reactions because it is perceived as directive or confrontational, especially by 
people who have not decided to change their behavior (Stott & Pill, 1990).
In summary, DA from physicians is associated with large numbers of people being 
able to quit smoking, even though only a small percentage of those who receive advice 
are able to quit. The effectiveness of physician advice is limited when it is not delivered 
frequently or consistently enough and when the form and/or content are not appropriate 
for the individual patient being advised.
Pharmacological Interventions
The two most widely used pharmacological interventions are buproprion and 
nicotine replacement therapy (NRT). Buproprion is newer than NRT and is only available 
by prescription. Though it has been shown to be effective (Hilleman et al, 1992) and is 
increasingly used for smoking cessation intervention, its mechanism of action is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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not well understood. NRT is the most readily available and widely used smoking 
cessation intervention, other than advice. Clinical Guidelines by the Agency for Health 
Care Policy and Research (AHCPR) recommend that physicians offer NRT to nearly all 
their patients who smoke (Fiore et al., 1996).
Nicotine gum (NG) and transdermal nicotine patches (TN) are available without 
prescription. Nicotine inhalers and nasal spray are newer forms of NRT that require a 
prescription and are not as widely used as NG and TN. In all its forms, NRT acts 
pharmacologically to suppress many of the physical withdrawal symptoms associated 
with smoking cessation (USDHHS, 1988).
Because NRT was designed for use with behavioral treatment (BT), there are few 
studies assessing the effectiveness of NRT alone (Klesges, Ward, & DeBon, 1996). In 
combination with BT, NRT has consistently been shown to be more effective than either 
placebo (PL) or no-NRT control (Fiore, Jorenby, Baker, & Kenford, 1992; Hjalmarson, 
Nilsson. Sjostrom, & Wiklund, 1997; Silagy, Mant, Fowler, & Lodge, 1994). A meta­
analysis by Silagy et al. of 53 randomized trials evaluating TN, nasal spray, and nicotine 
inhalers found that abstinence rates were 18.67% vs. 10.6% for PL at six months or 
longer. Abstinence rates for TN ranged from 22% to 42% vs. 2% to 28% for PL at six 
months in the comprehensive review of smoking cessation studies by Fiore et al. 
Abstinence rates for inhalers were 28% vs. 18% for PL at 12 months in a clinical trial by 
Hjalmarson et al.
Data about the various types of NRT indicate that it is most effective for smokers 
who are motivated to quit (Lam et al., 1987). Matching the amount of nicotine delivered 
to the smoker’s level of nicotine dependence also increases effectiveness, especially with
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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NG (Cepeda-Benito, 1993; Hjalmarson, et al., 1997; Hughes, 1993; Klesges et al., 1996; 
Silagy et al., 1994).
When BT and NRT are used together, they act in concert insofar as NRT affects 
mostly physical aspects of nicotine dependence while BT addresses the cognitive and 
behavioral elements of smoking (Cepeda-Benito, 1993; Fiore et al., 1994; Hjalmarson et 
al., 1997; Lam et al., 1987; Orleans. 1985; Schwartz, 1987; Silagy et al., 1994). Their 
primary effects are sequential: NRT acts on the withdrawal symptoms that predominate in 
early abstinence; then BT provides cognitive and behavioral skills for maintaining 
abstinence.
NRT has many strong points, including convenience, availability, usefulness for 
smokers who are highly nicotine-dependent, and relatively high cost-effectiveness. Its 
disadvantages include its cost, narrow focus on physical dependence, and high relapse 
rate (Cepeda-Benito, 1993; Schwartz, 1987; Silagy et al., 1994).
In summary, NRT is widely and effectively used to control the physical symptoms of 
withdrawal during the early stages o f smoking cessation. Its effectiveness is enhanced 
when it is used for smokers who are highly motivated to quit, when it is used in 
combination with BT, and when nicotine dosage is matched to the smoker's level of 
addiction.
Behavioral Treatment
BT is often useful for smokers who want or need more assistance than they receive 
from minimal interventions such as advice to quit or NRT. Usually offered through 
formal smoking cessation programs, BT addresses behavioral, psychological, social, and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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physical components of smoking (Brown & Emmons, 1991; Lichtenstein & Glasgow, 
1992; Orleans, 1985; Schwartz, 1987).
Behavioral techniques target smoking behaviors and physical dependence by creating 
tangible costs for smoking and rewards for abstinence, breaking up conditioned smoking 
behaviors, or diminishing physical dependence on nicotine. Cognitive components o f BT 
teach coping skills, problem solving, and self-management and often help smokers 
prevent relapse. The facilitator and/or other group members are sources of encouragement 
and social support (Lando, 1993).
The most effective BT programs produce long-term quit rates as high as 40% 
(Glasgow & Lichtenstein, 1987; Schwartz, 1987). Factors associated with effectiveness 
include multiple treatment components in the intervention (Klesges et al., 1996) and high 
intensity (e.g., length of sessions and duration o f treatment). The Smoking Cessation 
Clinical Practice Guideline by the Agency for Health Care Policy and Research suggests 
a minimum of four meetings, each lasting at least 20 minutes, spanning at least two 
weeks, with eight weeks or more being preferable (Fiore et al., 1996).
Setting a quit date and addressing motivation to quit and/or confidence in ability to 
quit are also associated with positive outcomes (Brown & Emmons, 1991; Klesges et al., 
1996; Schwartz, 1987; USDHHS, 1988). Formal BT programs are generally most helpful 
for smokers who are highly motivated to quit and are not heavily dependent on nicotine 
(Fiore e tal., 1996).
BT's strengths include comprehensiveness and flexibility. Some programs offer a 
menu of treatment options from which each smoker can choose a combination of 
interventions that meets his or her needs (Best, Owen, & Trentadue, 1978; Lando, 1984;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9
Lando, McGovern, & Sipfle, 1989). Others match program components to smokers' stage 
in the quitting process (Brown & Emmons, 1991).
Program complexity, low utilization and poor cost-effectiveness are drawbacks of 
BT. Multi-component BT programs pose special problems for evaluators because they 
vary greatly in the combinations of techniques they employ, making it difficult to 
compare studies meaningfully or to evaluate the relative effectiveness of component 
interventions. Only 15% of smokers who quit participate in behavioral smoking cessation 
programs (Fiore et al., 1990). Convenient, affordable BT programs can be difficult to 
locate and, when available, their timing may not coincide with a smoker's needs (Fiore et 
al., 1990; Hughes, 1995). In addition, most programs target smokers who are ready to 
quit, so they are inappropriate for smokers who are not yet at that level of readiness 
(Brown & Emmons, 1991; Prochaska et al., 1992).
In summary, BT addresses the cognitive and behavioral aspects o f smoking and can 
be used for individuals or groups. It is most effective for smokers who are motivated to 
quit and when it is combined with pharmacological treatments and presented in several 
sessions over several weeks. BT is more expensive than physician advice, but it meets 
needs of many smokers that are not addressed by physician advice or other smoking 
cessation interventions.
Physician advice, NRT, and BT interventions all share a common limitation: they are 
most effective for smokers who are motivated to qu it Providing an intervention that is 
helpful for those smokers who are not yet ready to quit and/or finding a way to increase 
the number of smokers who are ready to quit could dramatically improve smoking 
cessation outcomes from a public health perspective. In either case, it is important to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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understand the differences between smokers who are ready to quit and those who are not. 
One approach is Prochaska and DiClemente's (1983) stages of change (SOC) model. 
Stages of Change
The (SOC) model (Prochaska & DiClemente, 1983; Prochaska et al., 1992) provides 
a means of understanding the evolving needs of people who are in the process of 
changing their behavior. It has frequently been applied to smoking cessation 
(DiClemente, 1991; Glynn, Boyd, & Gruman, 1990; Prochaska & DiClemente, 1983; 
Prochaska & DiClemente, 1986; USDHHS, 1988). The model has been shown to be both 
reliable and valid (DiClemente et al., 1991). While it is most often associated with 
changing addictive behaviors, the SOC model can be applied more generally. It describes 
all kinds of human behavior change, including both self-change and change occurring in 
therapeutic settings (Prochaska & DiClemente, 1983; Prochaska et al., 1992).
The benefits of matching interventions to stage o f change are widely recognized 
1992; Rollnick, Kinersley, & Stott, 1993; Velicer et al., 1995). In smoking cessation 
interventions, matching to stage of change can increase the probability o f  successful 
quitting. For example, progressing to the next greater stage of readiness early in smoking 
cessation treatment has doubled the probability that a smoker, regardless o f beginning 
stage, will ultimately quit (Prochaska et al., 1992).
In the SOC model, the person who is changing his or her behavior is seen as moving 
from being unaware or unconcerned about the problem through considering change, 
deciding to act, taking action, and, finally, maintaining the change. Each of the preceding 
levels of commitment to change is considered a stage. Prochaska et al. (1992) describe the 
five stages, pre-contemplation (PC), contemplation (Q , preparation (PA), action (A), and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
maintenance (M), in more detail. The stages are based on intention to change, immediacy 
of any plans to change, and actions taken.
In PC, people do not intend to change their behavior in the near future. They may be 
unaware that the behavior is a problem or they may want to change sometime, but not in 
the next six months.
Those in the C stage recognize that their behavior is a problem. They are seriously 
thinking of changing it within the next six months, but have not yet committed to taking 
action to quit. People in the C stage are ambivalent as they weigh the advantages and 
costs of change versus continuing the behavior (Prochaska et al., 1992).
People in the preparation stage have decided to change within the next month and 
have tried, but failed, to change within the past year. They may be making preparatory 
changes in their behavior such as smoking only at set times (Prochaska et al., 1992).
In the action stage, people take definite steps to change their behavior. This stage 
lasts from one day to six months and may involve altering the environment to support the 
behavioral changes they are making. For example, they may avoid people and situations 
they associate with smoking.
People in the maintenance stage have been free of the behavior for at least six 
months. They may still be making changes in their environment and behavior to prevent 
relapse (Prochaska et al., 1992).
Relapse, while not a stage in this model, is a critical part of the process of change. 
Most people who successfully quit addictive behaviors, for example, have made between 
one and four unsuccessful quit attempts (Ahijevych & Wewers, 1992). It is helpful for 
people attempting change to prepare for relapse. When seen as a failure, a relapse can
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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inhibit interest in changing, causing some to return to an early stage (e.g., PC or C) where 
they may remain for long periods of time. Those who understand that it is a common part 
of the process they are experiencing are more likely to return to the C or preparation 
stages. Approximately 85% of people who relapse do, in fact, return to the C or 
preparation stages (Prochaska & DiClemente, 1984, 1986). This tendency has led 
Prochaska et al. (1992) to liken the progression through the stages to a spiral in which 
people move through the stages from PC to action, then recycle to either the C or 
preparation stage from which they make another quit attempt.
Interventions that are matched to stage offer the smoker who is trying to quit 
multiple opportunities for success before achieving abstinence. Encouraging people 
attempting behavior change to see relapse as one setback among many successes 
differentiates stage-matched treatments for addiction from treatments based on all-or- 
none concepts of behavior change. The successes achieved in stage-matched treatment 
can be highly reinforcing for both the smoker and the provider of smoking cessation 
interventions.
In addition to providing opportunities for reinforcement, stage-matched interventions 
foster motivation because they seldom provoke resistance (Rollnick et al., 1993). 
Providing information that is not matched to stage has been shown to be counter­
productive for those who are unmotivated to change (Ockene et al., 1991). Describing 
quitting techniques, for example, which is an appropriate intervention for people who 
have already decided to quit, may alienate pre-contemplators and contemplators. On the 
other hand, Prochaska, Norcross, & DiClemente (1994) found that pre-contemplators 
responded positively to stage-matched interventions that increased their awareness of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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smoking as a problem for them or that relieved their concerns about smoking by 
encouraging greater readiness to change.
Stage-matched interventions are consistent with patient-centered care, which 
Ockene, Ockene & Kristeller (1988) found to be especially effective for smoking 
cessation. Stage-matched smoking cessation interventions are characterized by 
identification of smokers' needs, attempts to meet those needs, and a central role for the 
smokers' participation, which creates a more egalitarian relationship than between advice- 
givers and advice-receivers. In addition, change is recognized as a process that takes time 
(Goldberg et al., 1994).
In their study of the stage distributions of smokers in three populations, Velicer et al. 
(1995) argue that matching can increase recruitment to smoking cessation programs, 
enabling them to have a greater impact. Impact is defined as the effectiveness of an 
intervention multiplied by its recruitment rate. The authors note that neither clinical nor 
public health approaches currently have a high impact on smoking because clinical 
interventions, while effective, reach relatively few people, and public health interventions 
target entire populations but are not very effective.
One way for clinical interventions to reach more people is for them to meet the needs 
of smokers who have not yet committed to quitting. Crittenden and colleagues (1994; 
1998) studied smokers who were unmotivated to change. They found that smokers in the 
PC stage may be differentiated by attitudes and behaviors into three subgroups, which 
they have labeled PCI, PC2, and PC3. Those in PCI are not planning to quit or cut down; 
those in PC2 are not planning to quit, but are seriously planning to cut down on the 
amount they smoke; and those in PC3 are seriously thinking of quitting or are planning to
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quit, but not within the next month. The authors have designed a measure that can be used 
to assess the effects of interventions among smokers who are not motivated to quit. It is 
brief, sensitive to changes in readiness within the PC stage, and written to accommodate 
limited reading skills.
In summary, the SOC model describes behavior change in general and is often 
applied to changing addictive behaviors. Interventions that are matched to SOC are 
effective for smoking cessation. Progressing to the next stage has been shown to double 
the likelihood that a smoker will quit successfully, and stage progression is reinforcing for 
both smokers and providers. Stage-matched interventions can increase the impact of 
smoking cessation interventions because they elicit little resistance from pre- 
contemplators and contemplators, and can potentially increase the number of smokers 
who participate in smoking cessation programs. Stage-matched interventions targeting 
smokers who are not ready to quit may increase the impact of smoking cessation efforts. 
Changes in readiness among smokers in the PC stage may be measured using the 
elaborated stages of change model (Crittenden et al., 1994).
Motivational Interviewing
MI is stage-matched, client-centered, and has been used widely and effectively with 
alcohol abusers in early stages of behavior change (Miller & Rollnick, 1991). It has also 
been used effectively for smoking cessation (DiClemente, 1991). MI is especially useful 
for people in the early stages of behavior change (PC and C stages) because of its non- 
confrontational nature and its emphasis on the smoker’s ambivalent feelings about his or 
her smoking (Miller & Rollnick, 1991).
It may be that ambivalence accounts, at least in part, for the minimal effect
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traditional smoking interventions have on smokers in the C stage. These smokers tend to 
vacillate between thinking about continuing to smoke or trying to q u it Miller and 
Rollnick (1991) point out that smokers who are ambivalent assert their autonomy in the 
face of admonitions to quit by arguing (often to themselves) in favor o f the status quo. 
This increases their investment in continuing to smoke, thus lessening the likelihood that 
they will decide to quit. Miller and Rollnick contend that people experiencing 
ambivalence about changing their behavior are particularly vulnerable to the effects of 
making the argument for one side or the other of their dilemma. Their tendency to see one 
side and then switch to the other may appear to be resistance, but it is a normal response 
to their situation. It is not a reaction limited to people who engage in addictive behaviors, 
but is characteristic of anyone facing such a dilemma.
In Ml, the therapist works with ambivalence and the need for autonomy by 
encouraging the client to explore his or her ambivalence and move toward behavior 
change at his or her own pace (Rollnick, Heather, & Bell, 1992). Once the ambivalence is 
resolved, some individuals change on their own and others need further support to make 
and maintain behavior change (Miller & Rollnick, 1991).
There are several ways to conceptualize early stage behavior change and the role of 
the therapist. For example, the PC and C stages may be seen as a continuum of increasing 
awareness in which ambivalence grows as awareness o f the pros and cons of both 
continuing the behavior and giving it up increases (Miller & Rollnick, 1991). In this view, 
the therapist's role is to tilt the decisional balance toward behavior change by drawing out 
the client's reasons for behavior change and perceptions of the disadvantages of 
continuing the behavior (Miller, 1983).
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Miller (1983; 1985) suggests that the social psychological theory of cognitive 
dissonance provides another way to describe early-stage behavior change. Cognitive 
dissonance theory proposes that awareness of their inconsistencies compels people to 
change in ways that reduce the inconsistencies. Thus, as smokers' awareness of the 
incompatibility of their smoking with their beliefs, attitudes, or feelings increases, they 
are motivated to resolve the inconsistency. Resolution can come through changing either 
their behavior (e.g., quitting) or their beliefs, attitudes, or feelings (e.g., embracing 
smoking as an acceptable behavior). The role of the therapist is to increase the dissonance 
and then direct it so the person chooses behavior change, as opposed to continuing the 
self-defeating behavior. This is done by eliciting self-motivational statements, providing 
personalized feedback, and, for some contemplators, assisting the client with goal-setting 
(Miller, 1983, 1985; Rollnick et al., 1992).
Positive interpersonal influences on motivation grow out of empathic strategies such 
as minimizing directiveness and providing choice. Negative interpersonal effects have 
been found to result from more directive approaches. In a family therapy study, therapist 
and client behaviors affected each other so that clients' non-compliant behaviors elicited 
more teaching and confronting behaviors from the therapist and vice-versa (Patterson & 
Forgatch, 1995). These findings suggest that providers may improve smoking cessation 
interventions by using empathic techniques and avoiding directive techniques such as 
teaching, and confronting.
Miller et al. (1993) provided further evidence o f the importance of therapist attitude 
and responses to client concerns in MI. They conducted a randomized study of the effects 
of counselor style on outcomes of a motivational intervention with problem drinkers. In
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both directive-confrontive and client-centered counseling conditions, confrontive 
behaviors by the therapist predicted more drinking at one-year follow-up. The outcome 
was not attributable to client variables. Therapist confrontation, which occurred eight 
times more frequently in the directive condition, was the main discriminant between the 
two groups.
The poor outcomes following therapist confrontation found by Miller et al. (1993) 
may result from the natural tendency of people to resist being told what to do, as 
described earlier. Therapist awareness of, and respect for, the client's values and feelings 
can prevent this polarization from developing (Miller & Rollnick, 1991).
For clients who smoke, the therapist using MI creates a warm, supportive 
environment, elicits and reinforces the client's own perceptions o f the pros and cons of 
both the behavior and change, and provides assessment and feedback. If the client appears 
receptive, the therapist also provides information about the risks of smoking, which can 
increase awareness, ambivalence, and cognitive dissonance. The therapist also avoids 
confrontation by using reflection in ways that acknowledge and redirect the client's 
statement so exploration can continue (Miller & Rollnick, 1991) and emphasizes the 
client's responsibility for making any changes (Miller, 1983). No further intervention is 
appropriate for most pre-contemplators because it is likely to exceed their readiness to 
change.
For contemplators, the therapist may also offer the opportunity to begin discussing 
quitting techniques such as alternative behaviors, change strategies, and possible goals. 
The client chooses goals and means to achieve them (Rollnick et al., 1992; Miller, 1983).
Rollnick and associates (Rollnick & Bell, 1991; Rollnick, Butler, & Stott, 1997;
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Rollnick et al., 1992) have developed a model of MI for use in medical settings. It was 
designed to help health care providers address behavior change sensitively, briefly, and 
effectively with patients in all stages o f readiness. A menu of stage-matched questions 
and strategies (See Appendix A) provides structure while allowing the interviewer 
flexibility to adapt to specific needs expressed by each patient This simplified model uses 
the basic concepts and elements of MI: Change is recognized as a process, and the goal of 
the intervention is for the patient to progress in readiness to change. Intervention 
strategies are matched to the patient's stage of readiness to change. The interviewer 
empathetically elicits and supports the patient's concerns about the behavior and reasons 
for wanting to change, attends to resistance, and does not direct or confront the patient.
There are several differences between the Rollnick et al. (1992) model and MI as 
previously described. The Rollnick et al. model has a more structured format and 
strategies are emphasized more than intervention skills. Consequently, it can be taught 
relatively quickly to health care providers who are not trained as counselors.
In summary, MI is a client-centered, stage-matched, behavior change intervention 
that addresses the ambivalence of people in the early stages of change. Empathic 
reinforcement and avoidance of confrontation significantly decrease the likelihood of 
defensiveness that often arises in response to more directive interventions. MI may be a 
particularly effective smoking cessation intervention. Increases in motivation to change, 
the goal of MI, have been shown to predict later quit attempts among smokers (Prochaska 
et al., 1992). Finally, a model o f MI has been developed for use in medical settings, 
where a large proportion of smokers are seen each year.
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The Current Study
This study was a clinical comparison of the effectiveness of MI, DA, and CC in 
increasing readiness to quit among male smokers in a VA primary care setting. Smokers 
were randomly assigned by baseline stage of change into the three groups using a 
guideline that ensured that the treatment groups contained approximately equal numbers. 
Participants' subsequent stage o f change, motivation to quit smoking, and actions taken 
toward quitting were assessed at baseline and again one and three months later. 
Demographic information, smoking history, perceived health status, and nicotine 
dependence level were also assessed.
Hypotheses
1. It was expected that the MI group would exhibit a greater shift in the positive 
direction in readiness to change, measured as contemplation ladder (CL) scores, than 
either the DA or CC groups. This shift was expected to occur between baseline and each 
follow-up assessment (i.e., time one to time two and time one to time three).
2. It was expected that the MI group would report more motivation to change than 
either the DA or CC groups at time two and time three.
3. It was expected that the MI group would report more actions to quit than either the 
DA or CC groups at time two and time three.
In addition, the following hypotheses were to be examined if there were enough data:
4. It was expected that the MI group would report greater reductions in the number of 
cigarettes smoked per day (cpd) than either the DA or CC groups at time two and time 
three.
5. It was expected that more smokers in the C than in the PC stage, across treatment
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hour quit attempt at time two and time three.




Because human subjects were used in this study, an application for approval of the 
study was filed with the Human Subjects Institutional Review Board at Old Dominion 
University. Approval had already been received from the Institutional Review Board at 
the Baltimore VA Hospital, the University of Maryland Medical Center, and the 
Washington VA Medical Center.
Participants were recruited from primary care patients at a VA medical center. They 
were either waiting to see their physicians or were at the hospital for outpatient services 
other than primary care on the day they were interviewed. Participants were 157 adult (at 
least 26 years of age), male, current smokers (5 or more cigarettes per day), and in either 
the PC or C stage of change. In all, 1,963 people were approached to take part in the 
study, 388 were identified as smokers, 201 agreed to participate, and 157 provided usable 
data.
The participants ranged in age from 26 to 79 years (M = 51.7, SD = 9.9) and had 
completed from 3 to 18 years of education (M = 12.7; SD = 2.1). Their self-perceived 
health status was good (M = 3.2, SD = 1.0) on a five-point scale ranging from poor ( I 
point) to excellent (5 points). Their lifetime cigarette consumption was estimated in pack 
years, a frequently used gauge of smoking history. Pack years are calculated by 
subtracting the smoker's age at onset of smoking from his or her present age to find the 
number of years of smoking, then multiplying that figure by the average number of packs 
smoked per day. Participants reported smoking an average o f 32.3 pack years (range = 3 
to 94; SD = 18.0) and were currently averaging 18.4 cpd (range = 5 to 60; SD =  10.6).
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A majority of all participants (59%) reported that their doctor talked with them about 
smoking. Nearly the same proportion (56%) of the participants reported that their doctor 
advised them to quit. A much smaller proportion (39%) of the participants said their 
doctor offered them help in quitting. Most of the participants indicated they were very 
happy with their physician’s smoking-related interventions, with over 87% endorsing the 
highest two of seven possible levels of satisfaction.
Participants indicated the same high degree of satisfaction with the interviews for the 
present study. Eighty-eight percent endorsed the highest two of seven satisfaction levels. 
Measures
Smoking Survey. The Smoking Survey (Appendix B) was created for this study by 
expanding the elaborated stages-of-readiness measure created by Crittenden and 
colleagues (1994), which is based on the SOC model of Prochaska et al. (1992). 
Crittenden et al. found that smokers falling within the PC stage of Prochaska et al. can be 
meaningfully separated into three subdivisions. The subdivisions differentiate between 
smokers who never plan to quit, those who are interested in cutting down, and those who 
plan to quit sometime, but not within the next six months. All other stages o f change (C, 
preparation, action, and maintenance) are the same as defined by Prochaska and 
colleagues.
The elaborated SOC measure (Crittenden et al., 1994) has been shown to have 
adequate internal reliability, stability, and predictive validity. In their 1994 study 
involving 495 women at four public health clinics, Crittenden et al. found support for the 
reliability of the motivation and confidence scales. The motivation scale had a Cronbach's 
alpha of .8 1; the confidence scale had an alpha of .67, thus demonstrating adequate
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internal reliability for both scales. For this study, alphas for motivation were .91 and .92; 
for confidence, they ranged from .75 to .90.
Crittenden et al. (1994) compared their elaborated SOC measure to the CL (Biener & 
Abrams, 1991), an alternative instrument for measuring readiness to change. Of the two, 
they found that the elaborated SOC measure was more strongly related to changes in 
motivation, confidence, and action.
The Smoking Survey requires minimal literacy. It provides the following information 
(item numbers shown in parentheses): demographic information and name of primary 
care provider; current smoking status (I); smoking history (2 ,3 ,4 ); stage of readiness to 
change (6, I I , 12, 15, 16); motivation to cut down or quit (7 ,9 , 13, 17); confidence in 
ability to cut down or quit (8, 14); actions taken in the past year to cut down or quit (5,
10, 11); and perceived health status (18 and 19). Questions added to the elaborated SOC 
measure (Crittenden et al., 1994) for this study are those pertaining to smoking history 
and perceived health status. Questions 2, 3, and 4  are used to calculate an estimate of 
pack years.
Two items were designed to indicate perceived health status. The first item (18) is a 
checklist of 13 of the most common smoking-related illnesses, plus a fill-in space for any 
other illness the participant may be experiencing that he believes is smoking related. This 
item is scored by summing the number o f endorsed illnesses. The second item (19) asks 
for a global estimate of health status. Participants rate their health by checking one of five 
responses ranging from poor (5) to excellent (IT The remaining items are taken directly 
from the Crittenden etal. (1994) measure and were used to determine SOC by algorithm.
Stage of Change. Questions used to assess SOC ask about intent to cut down,
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actually cutting down, 24-hour quit, intent to quit, and immediacy of that intent SOC is 
determined by algorithm, based on behaviors endorsed on the five stage-relevant items 
(see Table I). Four of the five items used to determine SOC are dichotomous (Yes/No), 
and the fifth offers four ranges of time from which participants select one. While three 
items on the questionnaire ask about behavior “one year ago” or “in the past year”(5, cpd 
one year ago; 10, cutting down in the last year; and 11, quitting for 24 hours in the last 
year), the wording was changed at follow-up assessments to ask about “at or since the 
last interview”.
Motivation. The four items that assess motivation to cut down and/or to quit ask 
about desire to cut down, desire to quit or stay quit, determination to cut down, and 
determination to quit or stay quit. Items used to measure motivation are all four-point 
scales from which the participant selects one ("Not at all," "A little," Somewhat," or 
"Very"). Items are scored from not at all (1) to very (4). Possible total scores for 
Motivation range from 4  to 16.
Confidence. Two questions measure confidence in ability to cut down or quit. Items 
used to measure confidence, like those for motivation, are ail four-point scales from 
which the participant selects one ("Not at all," "A little," Somewhat," or "Very"). Items 
are scored from not at all (1) to very (4). Possible total scores for Confidence range from 
2 to 8.
Action. There is one question for each of three actions taken in the past year (or since 
the last interview) to cut down or quit: intentionally quitting for 24 hours, cutting down 
during the past year, and smoking fewer cpd than at this time last year or at the last 
interview (calculated by subtracting cpd reported previously from current cpd).
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Table 1
Stages of Readiness to Change Smoking Behavior. Including Smoking Survey Items 
Endorsed by Participants in Each Stage.
STAGE DESCRIPTION ITEMS ENDORSED
12 Not thinking of quitting AND
PCI Not contemplating quitting AND 
no intent to cut down
15 Not planning to quit AND 
6 Not thinking of cutting down
12 Not thinking o f quitting AND
PC2 Not contemplating quitting BUT 
intending to cut down
15 Not planning to quit, BUT 
6 Thinking of cutting down
12 Seriously thinking of quitting OR
PC3 Contemplating quitting BUT 
not within 6 months
15 Planning to quit, BUT
16 Not within 6 months
12 Seriously thinking of quitting AND
C Contemplating quitting 
within 6 months
15 Planning to quit
16 Within 6 months BUT EITHER
16 No plan to quit within 1 month OR 
11 No 24-hour quit attempt
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12 Seriously thinking of quitting AND 
PA Preparation fo r  Action 15 Planning to quit AND
16 Within I month AND 
11 Made a 24-hour quit attempt
Note. PCI to PC3 refer to pre-contemplation stages I through 3; C refers to the 
contemplation stage, and PA refers to the preparation stage. From “Measuring Readiness 
and Motivation to Quit Smoking Among Women in public Health Clinics,” by K.S. 
Crittenden, C. Manfredi, L. Lacey, R. Wamecke, and J. Parsons, 1994, Addictive 
Behaviors. 19 (5). P. 500. Copyright 1994 by Elsevier Science Ltd. Adapted with 
permission.
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Each question counts as one point for a total possible score o f three. A fourth action, 
quitting, is possible at follow-up. Participants who quit received an action score of four.
The Contemplation Ladder. The CL (Biener & Abrams, 1991, Appendix C) is a 
continuous measure o f readiness to quit. It is a visual analog scale in the form of a ladder 
on which smokers are asked to mark the rung that most nearly corresponds to their 
readiness to change. The ten numbered rungs represent a continuum of readiness to 
change. The five labeled rungs are: no thought of quitting (0): think 1 need to consider 
quitting someday (2); think 1 should quit but not quite ready (5); starting to think about 
how to change mv smoking patterns (8); and taking action to quit (e.g., cutting down, 
enrolling in a program) (10).
The CL is a more useful measure for smokers in the early stages of change than for 
those in later stages. Biener and Abrams (1991) found that the CL predicted readiness to 
contemplate quitting, but not long-term cessation. Crittenden et al. (1994) found in their 
study of smokers in the early stages of change (pre-contemplation and Contemplation) 
that the CL was positively related to motivation to change as measured by their 
questionnaire. They found that CL was positively related to confidence, action, and stage 
of change when rungs one through three were contrasted with rungs four and five.
Fagerstrom Test of Nicotine Dependence (FTND). The FTND (Heatherton et al, 
1991, Appendix D) is a six-item measure o f nicotine dependence. Four items are 
dicliotomous (yes/no) and are scored either 0 or 1. The remaining two items have four 
possible responses which are scored from 0  to 3. For all items, higher scores indicate 
greater dependence. Total scores of seven or greater indicate high nicotine dependence. 
The FTND has been shown to have adequate internal consistency and concurrent validity
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in studies using biochemical measures of nicotine in both a non-clinical sample 
(Heatherton, et al., 1991) and a clinical sample (Payne, Smith, McCracken, McSherry, 
and Antony 1994).
Feedback Form. The feedback form (Appendix E) was created for this study. It asks 
whether the participant's physician discussed smoking with him, advised him to quit, or 
assisted him with quitting. It also includes two questions addressing the participant's 
satisfaction with both physician and experimenter interventions.
Procedures
Male primary care patients at an Eastern urban VA Medical Center were queried 
about their current smoking status. Current smokers who agreed to participate in the study 
were asked to complete a consent form (Appendix F), including agreement to participate 
in follow-up interviews and complete a Smoking Survey, the CL (Biener & Abrams,
1991), and the FTND (Heatherton et al, 1991). Participants were then assigned by SOC to 
one of three experimental interventions: MI, DA, or CC.
Smokers were randomized to treatment by assigning individuals from each SOC to 
treatment in a pre-determined order. Interventions occurred before physician visits to the 
extent possible. After their study intervention, participants completed the feedback form 
(Appendix E), and received a preliminary debriefing form (Appendix G) and wallet-size 
copy of the CL. Each intervention involved approximately 15 minutes of contact with the 
experimenter.
Follow-up interviews for each subject were conducted one month and three months 
after the intervention. Participants were re-administered the Smoking Survey, the CL 
(Biener & Abrams, 1991), and the FTND (Heatherton et al, 1991) either by telephone or
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in person. Each follow-up contact lasted approximately ten minutes.
Audio recordings were made o f all interventions for which participants consented to 
be recorded. The recordings were evaluated by objective raters using checklists of the 
major defining criteria for each intervention (Appendix H). The raters, who were graduate 
students in clinical psychology, were naive to the purpose of the study. This manipulation 
check was performed to ensure treatment adherence and consistency because one 
experimenter administered all three interventions.
MI interventions were conducted using stage-matched strategies from the menu 
shown in Appendix A. This menu was adapted from menus created by Rollnick and 
colleagues (Rollnick & Bell, 1991; Rollnick, Butler, & Stott, 1997; Rollnick, Heather, & 
Bell, 1992). The list of strategies is ordered by level of readiness to change. Strategies at 
the top of the list are appropriate for most smokers, regardless of stage. Each subsequent 
set of strategies is for smokers who endorse greater readiness to change, with the last set 
being appropriate for smokers in the C stage.
In the DA intervention, participants were instructed about the health risks of 
smoking, the benefits of quitting, and techniques for smoking cessation. Participants were 
told about the health consequences that they might experience if they continued to smoke 
and were firmly advised to quit Those who minimized the relevance of the advice, or 
argued against it, were authoritatively reminded of the risks associated with continuing to 
smoke and advised that they should quit as soon as possible. The DA intervention was 
designed to be an analogue for advice participants are likely to encounter in a primary 
care setting (Ockene et al., 1991).
CC was a discussion of lifestyle/health-related behaviors, which was conversational
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
30
in tone and did not address topics the participant indicated he associated with smoking 
such as smoking-related illnesses endorsed on the Smoking Survey. When such topics 
arose, they were acknowledged and the conversation was re-directed to a subject that was 
not related to smoking.




Stage of change and Contemplation Ladder. Two measures of readiness to change 
were used in this study: Crittenden’s elaborated SOC model (1994) and the CL (Biener & 
Abrams, 1991). Dividing pre-contemplators into the three stages of the elaborated SOC 
model and then into three intervention groups resulted in numbers of participants in PCI 
and PC2 that were smaller than in PC3 and C. All but one of the resulting PCI and PC2 
groups had less than ten participants, which made them too small for meaningful analysis 
(see Table 2). Combining the PCI and PC2 groups resulted in numbers that were large 
enough to be analyzed and similar in size to the PC3 and C stages. The resulting stages 
are designated PC1/PC2, PC3, and C.
Assigning participants to SOC presented difficulties in some cases. Several 
participants gave responses that prevented them from being classified according to the 
algorithm. In addition, the continuous data provided by the CL were judged to be 
preferable for analytic purposes compared to the ordinal data of the SOC model.
To investigate whether the CL could be used as the dependent variable (DV), 
preliminary analyses were conducted to assess the degree to which the CL and SOC were 
related. A one-way General Linear Model (GLM) analysis was done for three levels of 
SOC with CL scores as the DV. A main effect of SOC on CL scores was found at time I, 
F (2, 154) = 46.06, p <  .001; time 2, F (2, 108) = 39.38; p <001; and time 3, F (2,99) = 
36.129, p < .001. In each case, a Scheffe post hoc test revealed that PC1/PC2 had lower 
CL scores than PC3. which had scores lower than C. Mean CL scores by SOC are shown 
in Table 3.
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Table 2
Number of Participants in Each Stage of Change And Intervention.
Stage Of Change
Intervention I 2 3 4 TOTAL
Direct Advice 9 8 21 14 52
Motivational Interviewing 9 9 18 18 54
Control Conversation 11 8 17 15 51
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Table 3
Mean Contemplation Ladder Scores bv Stage of Change
Stage
Time I Time 2 Time 3
Mean S.D. Mean S.D. Mean S.D.
PC1/PC2 2.96 2.39 2.20 2.57 2.48 2.68
PC3 6.27 2.68 6.19 2.68 6.00 3.00
C 7.53 2.39 7.74 2.26 8.24 2.35
TOTAL 5.51 3.14 5.89 3.26 6.20 3.45
Note. PC1/PC2 refers to combined pre-contemplation groups I and 2. PC-3 refers to the 
pre-contemplation 3 group. C refers to the contemplation group.
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Attrition and completion groups. Of 201 participants who completed at ieast part of 
the consent form and initial questionnaires, 28 were eliminated. The reasons for 
elimination from the study included: refusal to continue in the study (4), and 
disqualification because they did not meet the inclusion criteria (21) or ineligibility 
because their data were collected during the pilot stage of the study (3). Of the remaining 
173 participants considered for the study, 157 had valid data for one or more interviews. 
Of the 16 participants whose data were invalid, one was in the preparation stage of 
change (e.g., SOC = 5), 12 smoked less than five cpd, and three could not be assigned to a 
stage. The stage and intervention distribution of the 157 participants whose data were 
used in the study can be seen in Table 2.
Not all participants participated in all three interviews. They were assigned to 
attrition groups based on the number of interviews they had completed. Attrition groups 
were then compared to determine what, if any, differences existed among groups 
completing different combinations of interviews with respect to variables such as initial 
stage of change, age, and current smoking level. The first group consisted of 99 
responders to all three interviews. The second group consisted o f 20 responders to the 
initial and one-month follow-up interviews. The third group consisted of 27 responders to 
the initial interview only. The 11 participants who completed interviews at times 1 and 3 
only were excluded from the attrition group analyses.
No significant differences were found among the attrition groups for initial SOC, £  
(4, n = 139) = 1.51, g  = .83, or quitting, £  (2, n = 146) = 1.12, p =  .57. These data are 
presented in Table 4.
A one-way (attrition group) MANOVA, between subjects, was done with motivation,
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Table 4
Stage of Change Distribution and Reported Quit Attempts by Attrition Group
Stage Group 1 Group 2 Group 3 Total
PC1/PC2 
(n = 44)
30% (n=29) 41% (n=7) 31% (n=8) 32%
PC3
(n=54)
39% (n=37) 41% (n=7) 39% (n=!0) 39%
C
(n=4l)
31% (n=30) 18% (n=3) 31% (n=8) 29%
Total
(N=139)








49% (n=49) 40% (n=8) 56% (n=15) 49%
Total
(N=146)
100% (n=99) 100% (n=20) 100% (n=27) 100%
Note. Group 1 completed all three interviews. Group 2 completed interviews 1 and 2. 
Group 3 completed interview I only. PC1/PC2 refers to combined pre-contemplation 
groups 1 and 2. PC-3 refers to the pre-contemplation 3 group. C refers to the 
contemplation group.
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current smoking level, confidence, age, FTND, and perceived health as DVs. There was 
no significant effect of attrition group, multivariate F (12,274) = 1.21, g = .28 (see Table 
5).
In order to examine the issue of attrition further, those who completed all three 
interviews (i.e., completers) were compared to those who did not complete all three 
interviews (i.e., noncompleters). Using the same variables as those described in the 
analyses for attrition groups, there were no significant differences between completers 
and noncompleters. In summary, there were no significant differences among the attrition 
or completion groups on the variables analyzed.
Manipulation Check. One investigator conducted all interventions, as well as the 
one-month and three-month follow-up interviews. To evaluate the interviews, two raters, 
who were unaware of the purpose of the study, scored 24 tapes, eight from each 
intervention. DA and MI were each represented by three descriptors, and the CC by one 
(see Appendix H). The raters were given oral instructions before evaluating the tapes (see 
Appendix I). Their scoring was in agreement for 96% of the taped interviews. They both 
correctly endorsed 23 of 24 descriptive statements for both DA and MI, and all eight 
descriptors for the CC. They both also endorsed a descriptor for MI (“listens, reflects 
back, and summarizes what the smoker has said”) for all CC interviews and for seven and 
eight DA interviews, respectively.
Main Analyses
The first hypothesis predicted participants in the MI group would show greater 
increases in readiness to change from baseline to each follow-up assessment than 
subjects in either the DA or CC conditions. A 3 (intervention) x 3 (time) mixed design
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Table 5









Mean SD Mean SD Mean SD Mean SD
Motivation 11.72 3.96 12.12 4.23 11.35 4.70 11.70 4.11
Current
Cigs/Day 18.52 10.36 19.05 11.80 20.69 11.01 18.98 10.64
Confidence 5.34 2.20 5.15 2.23 5.81 2.00 5.40 2.16
Age 52.15 10.11 50.30 9.96 53.50 9.99 52.14 10.04
FTND 4.61 2.47 4.60 2.26 5.50 2.20 4.77 2.41
Perceived
Health 3.30 0.98 2.80 1.15 3.42 0.95 3.26 1.01
Note. Group 1 completed all three interviews. Group 2 completed interviews 1 and 2. 
Group 3 completed the initial interview only.
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GLM was done using CL scores as the DV. There was no main effect of intervention, F 
(2, 96) = .70, p > .05. There was a main effect of time, F (2, 192) = 4.86, p  < .01, 
indicating significant differences in readiness to change (CL scores) over time (see Table 
6).
The second hypothesis predicted all participants in the MI group would report more 
motivation to change than subjects in either the DA or CC conditions at each follow-up 
assessment. A 3 (intervention) x 3 (time) between-within GLM was done using 
motivation as the DV. There was no effect of intervention. F (2,92) = 1.25, p = .29. There 
was a significant time-by-intervention interaction, F (4, 184) = 2.76, p < .05 as well as a 
significant main effect for time, F (2, 184) = 6.07, p < .01.
A simple effects analysis was used to examine motivation changes over time for each 
intervention condition. A Bonferroni correction was done to adjust error for the three 
analyses. The alpha used was .017. This indicated that those in the MI group and the DA 
group did not change significantly over time, F (2,60) = 3.64, p = .03, F (2.56) = 1.22, p = 
.30, respectively. The CC group did change significantly over time, F (2 ,68) = 6.90, p  = 
.002, indicating that changes in the CC group accounted for both the main effect of time 
and the intervention-by-time interaction (see Figure 1).
The third hypothesis predicted that all participants in the MI group would report 
more actions to quit from baseline to each follow-up assessment than subjects in either 
the DA or CC conditions. A 3 (intervention) x 2 (time) between-within GLM was done 
using action as the DV. There was no main effect of intervention, F (2,71) = .24, p = .78, 
nor of time, F (1,71) = .96, p  = .33. Neither was there a time-by-intervention interaction, 
F (2, 71) = .73, p = .49.
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Table 6
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Figure 1. Motivation scores by intervention at three assessment times.
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The fourth hypothesis predicted that all participants in the MI group would report 
greater reductions in cpd from baseline to each follow-up assessment than subjects in 
either the DA or CC conditions. A 3 (intervention) x 3 (time) GLM was done using cpd as 
the DV. There was no main effect of intervention, F (2,96) = .26, p = .77, nor was there a 
time-by-intervention interaction, F (4,192) = .739, p = .57. There was a main effect of 
time, F (2, 192) = 18.00, p < .001, indicating that smokers in all intervention groups 
smoked less over time. The decrease in mean cpd for each intervention group is shown in 
Figure 2.
The fifth hypothesis predicted that, at each follow-up assessment, more 
contemplators than pre-contemplators would report cutting down or quitting for twenty- 
four hours. Two chi-square tests were done for each follow-up assessment (time two and 
time three, making four tests in all), using contemplation group (pre-contemplator or 
contemplator) and either cutting down or quitting as the variables. Results for cutting 
down and quitting were mixed. Contemplators were significantly more likely than pre- 
contemplators to cut down at time three, (1, n = 110) = 5.08, p < .05, but not at time 
two, x i (1. n =119) = 2.21, p = .137. Contemplators reported significandy more quit 
attempts at time three, 3̂  (I, n = 110) = 9.71, p < .05. There was also a trend for 
contemplators to make more quit attempts than pre-contemplators at time two, ( I, n =
119) = 3.73, p = .053 (see Table 7).
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Figure 2. Cigarettes per day by intervention at three assessment times
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Table 7
Proportion of Smokers Cutting Down and Quitting at Interviews Two and Three
Cut Down Quit
Interview 2 Interview 3 Interview 2 Interview 3
Group Y N Y N Y N Y N
PC 57.8% 42/2% 60.5% 39.5% 24.1% 75.9% 32.9% 67.1%
n =48 n = 35 n = 46 11 = 30 n =20 n = 63
anCl
inIICl
C 72.2% 27.8% 82.4% 17.6% 41.7% 58.3% 64.7% 35.3%
n = 26 n = 10 p II N) 00 n = 6 n = 15 n = 21 n = 22 n =  12
Note. PC refers to participants in the pre-contemplation stage of change. C refers to 
participants in the contemplation stage of change.
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DISCUSSION
This was a preliminary study comparing MI to DA and CC for increasing 
readiness to quit among smokers who were not considering quitting in the near future. 
Participants were male primary care patients at a VA medical center. It was predicted 
that, following intervention, smokers receiving MI would increase more than other 
participants in readiness to quit, motivation to quit, and actions to quit, and that they 
would smoke fewer cpd. Hypotheses also predicted that participants who were most ready 
to change (contemplators) would report more cutting down and attempts to quit for 24 
hours or longer than those who were less ready to change (pre-contemplators). None of 
the hypotheses predicting that MI would be superior to DA or CC were supported.
Results partially supported the hypothesis that more contemplators than pre- 
contemplators would report cutting down and making 24-hour quit attempts at each 
follow-up interview. Contemplators reported significantly more cutting down and quitting 
than pre-contemplators only at time three. Over the course of the study smokers in all 
intervention conditions decreased their smoking behavior. They increased in readiness to 
change their smoking behavior and they decreased in cpd. This discussion describes 
possible reasons for these results.
The first hypothesis predicted that participants in the MI group would increase 
more in readiness to change than participants in the DA or CC groups. The second 
hypothesis suggested that smokers receiving MI would increase more in motivation to 
quit than smokers in other treatments. Contrary to both hypotheses, results revealed no 
effect for intervention. Participants in all interventions combined increased over time in 
readiness to change. Those in the CC group increased significantly in motivation to
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change. Several possible factors that may have contributed to these findings will be 
reviewed later in a separate section on study limitations.
The third, fourth and fifth hypotheses examined different aspects o f the actions-to- 
quit score. The actions-to-quit score is a composite of cpd, reported cutting down, and 
reported 24-hour quit attempts. The four positive actions to quit are smoking fewer cpd 
than at the last assessment, reporting at least one instance of cutting down, reporting at 
least one 24-hour quit attempt, and quitting.
Hypothesis three predicted that actions to quit would be higher for those in the MI 
group than for those in either DA or CC conditions. Contrary to the hypothesis, 
intervention was not related to actions to quit. The actions-to-quit score did not change 
significantly over time for the participants as a whole, either. Change in cpd was in the 
positive direction at each assessment time, but it was offset by negative change in 
reported cutting down and reported quitting (i.e., cpd was lower, but frequency of 
reported cutting down and quitting were also lower). The result was that there were no 
significant differences in the actions-to-quit scores at any assessment time.
Contrary to the prediction of hypothesis four, there was no effect of intervention 
on cpd. Participants in all intervention conditions decreased in cpd over time. Mean cpd 
dropped from 18.52 at time one to 15.21 at time two, and 13.98 at time three. The overall 
decrease in cpd may have been in response to physician counseling during the study or to 
combined focus on smoking by the experimenter and participants’ physicians. Physician 
counseling will be discussed more fully later in this section. Other possibilities include a 
demand effect from knowing that the study was about smoking cessation, and 
environmental effects, such as increasing c o s t Very high ratings for satisfaction with the
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intervention interviews (M = 6.26 out of 7) and a bias toward framing them in a positive 
light (“gave me food for thought” rather than “told me what to do” or “neither”) provide 
support for the possibility of a demand effect Many participants mentioned increasing 
cost as a reason for smoking less.
As predicted in hypothesis five, more contemplators than pre-contemplators 
reported cutting down and making quit attempts at time three (82% vs. 61%, 
respectively). According to Prochaska and DiClemente’s (1983) definition, contemplators 
are thinking of quitting within six months and are considering the advantages and 
disadvantages of quitting, while pre-contemplators are not thinking of quitting. 
Contemplators’ higher reported rates of cutting down and attempted quitting are 
consistent with the study of DiClemente et al. (1991) in which 24% of contemplators 
reported a quit attempt during the previous month, versus 8% of pre-contemplators.
The findings for hypothesis five are consistent with the SOC model (Prochaska & 
DiClemente, 1983; Prochaska, et al., 1992) in that contemplators reported more cutting 
down and quit attempts than pre-contemplators. However, the rates of reported cutting 
down and quit attempts in the current study are much higher than reported elsewhere for 
smokers in the PC and C stages (DiClemente et al., 1991). It is possible that participation 
in a study about smoking or providing information in a medical setting led participants to 
overestimate their rates of cutting down or quitting.
No studies evaluating both MI and DA were known to the experimenter prior to 
implementing this preliminary study. Therefore, there were no studies to which outcomes 
of hypotheses one through four could be directly compared. The existing smoking 
cessation literature did suggest, however, that MI would be more effective than DA
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(Ockene et al., 1991; Patterson & Forgatch, 1985; Prochaska, 1996). Outcomes for 
hypotheses one through four did not support the superiority of MI for increasing 
motivation to quit for this population in this setting.
Limitations of the Present Study
Some difficulties in carrying out this study were anticipated and attempts were 
made to overcome them. For example, to ensure equal numbers of subjects in each 
condition, a system was devised for assigning participants to intervention by stage of 
change. The possible effects of having one person provide all the treatments were 
addressed by developing guidelines and a menu of stage-matched questions and strategies 
to standardize the interventions as much as possible. In addition, recorded interviews 
were evaluated for treatment compliance by naive raters, who were graduate students in 
clinical psychology.
Despite efforts to anticipate difficulties and mitigate their effects, some were 
likely to have had adverse effects on the outcome. Factors that may have contributed to 
the lack of an effect for intervention include physician contact, participant characteristics, 
demand characteristics, the limited dose and intensity o f the intervention, having one 
experimenter deliver all three interventions, factors affecting treatment delivery, and 
lower-than-expected statistical power. Each of these factors will be discussed below.
Participants are likely to have been influenced by counseling from their physicians. 
After the study was planned, it was learned that a nationwide VA initiative to increase 
assessment of smoking status in VA primary care had been implemented prior to the 
beginning o f the study. Criteria for the initiative during fiscal year 1999 (October, 1999 
through September, 2000) included screening all primary care patients for smoking status
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and counseling each smoker at least one time per year. Counseling included either referral 
to a smoking cessation clinic or advice to quit. This urban VA medical center had a high 
rate of compliance with the initiative (C. McSherry, personal communication, August 14, 
2000).
Smokers in this study indicated a very high level of satisfaction with their 
physician’s interventions. The emphasis on smoking interventions in primary care, along 
with the participants’ high level of acceptance of their physicians’ advice, may have 
diluted any observable effects of interventions in this study. Because the primary care 
initiative was unanticipated, no data were collected about participants’ contact with their 
physicians during the study.
Health concerns or veteran status may have had a stronger effect on overall 
outcomes than any of the interventions, or they may have caused participants to respond 
more positively to the CC and DA interventions than to MI. The mean age of the 
participants was 51.7 years and the mean number of smoking-related illnesses they 
reported was 1.33. While this number appears to be low, the illnesses endorsed were 
chronic conditions, including several affecting the cardio-vascular system, as well as 
cancer and diabetes (see Appendix B). Heightened health concerns have been found to be 
positively associated with increased quit rates (Law & Tang, 1995). They have also been 
cited as one possible cause of higher quit rates among older smokers than for those who 
are younger (Ruchlin, 1999). Six o f the eight participants in this study who quit smoking 
reported that they were motivated by adverse health events, primarily “strokes.” The other 
two who quit cited family or environmental influences. It may be that the CC condition 
with its non-threatening focus on health concerns increased the salience of such concerns
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for the smokers. DA was also strongly health-focused, while motivational interviews 
were supportive of health-enhancing accomplishments, but centered more on the role of 
smoking in the participant's daily life along with associated feelings and conflicts 
identified by the participant Health concerns were sometimes discussed in this context, 
but were not the intended focus of the interview.
Demand characteristics may have been created for some participants by the 
medical center setting or by their knowledge that the study pertained to smoking 
cessation. If such was the case, their responses may have reflected a bias toward 
indicating greater readiness to quit or quitting-related behavior than was actually the case.
Tailored interventions such as MI have been shown to be superior to treatments 
such as DA (Miller, et al., 1993; Ockene, et al., 1991). Previous research has revealed that 
DA is less personalized and more likely to be perceived as confrontational because people 
tend to resist being told what to do (Rollnick, et al., 1993). However, DA may not have 
elicited such resistance among participants in this study. All participants were trained to 
respond to direct or implied commands as part of their military training and experience.
In addition, many of the participants were enrolled in long-term outpatient programs at a 
VA hospital for post-traumatic stress disorder (PTSD) or for substance abuse. There may 
be an effect from participation in such long-term programs that increases the comfort of 
their members with directly discussing their smoking habits. If so, they might be less 
likely to respond negatively to DA. Some support for this possibility came from the many 
participants in both long-term programs and this study who related quitting smoking to 
quitting other substances, often with the aid of 12-step programs. Their descriptions of the 
techniques that had been helpful for them were more similar to DA than to MI. In
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addition, PTSD and abuse of other substances in addition to tobacco are both associated 
with heavy smoking among veterans (Beckham, 1999; Beckham, et al., 1997). Heavy 
smoking is often associated with difficulty in quitting (Lam, et al., 1987; USDHHS, 
1988). Participants’ history of heavy smoking may have limited the effect of the 
interventions. The mean number of pack years for this sample was 32.26 and their mean 
cpd at time one was 18.12.
Interviews for this study were brief, averaging about seven minutes. While 
physician interventions for smoking have been found to be much shorter than seven 
minutes (Fiore, et al., 1996; Humair & Ward, 1998; USPHS, 2000), optimal smoking 
cessation interventions involve more time and intensity and include pharmacological 
agents such as nicotine patches orZyban (USDHHS, 2000). One short interview was 
likely not intense enough to produce a significant impact on the smoking habits of the 
participants in this study, who were mostly long-term smokers.
Delivery of all three interventions by one experimenter was a major limitation of 
this study, despite efforts made through planning, training, and practice to prevent 
experimenter bias or drift. Scenarios for all three interventions were planned in advance. 
For example, DA interviews included feedback regarding any health problems the 
participant endorsed, information about other smoking-related illnesses experienced by 
long-term smokers, admonitions to quit as soon as possible to prevent further smoking- 
related health problems, information about quitting techniques, and additional advice to 
quit. Motivational interviews followed the menu of stage-matched questions and 
strategies shown in Appendix A. The CC condition focused on participants’ current 
practices regarding diet, exercise, stress management, and sleep.
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The experimenter, who was trained in clinical psychology, completed specialized 
training in motivational interviewing. She practiced the direct advice scenario with 
volunteer interviewees in advance of implementing the study. She also prepared 
guidelines for structuring each of the three interviews. Nonetheless, objective raters, who 
otherwise identified all the interventions accurately, endorsed a characteristic of MI, 
“listens, reinforces, and summarizes,” for all but two of the taped DA and CC interviews. 
This indicates that elements of the experimenter’s clinical style such as empathy and 
reinforcement may have further diluted any differences that occurred among the three 
interventions. For example, in the DA condition, “reinforcement” and “support,” both of 
which were found by Patterson & Forgatch (1995) to enhance compliance, may have 
counteracted the effects of “teaching” and “confronting” that elicited non-compliance in 
the Patterson and Forgatch study.
The interventions probably would have been more effective if space and time had 
allowed for them to be conducted in an office as a part o f patients’ health care visits. They 
might also have carried more impact if conducted by participants’ regular health care 
providers. Conditions under which the interventions were delivered were very different 
from those one would expect for delivery of services in a health care setting. Office space 
was usually unavailable, leaving many interviews to be conducted in waiting areas of 
primary care clinics where privacy was limited. Assessment and interviews were 
conducted during patients’ waiting time, which was typically unpredictable in terms of 
duration and number of interruptions. Other interviews were conducted in designated 
smoking areas where many smokers congregated. Privacy was less problematic during 
most of those interviews, but distractions may have diminished their effectiveness.
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Treatment delivery conditions may also have resulted in a less representative 
sample than could have been obtained if interventions had been integrated into patients’ 
regular care. Approaching patients in public areas resulted in numerous refusals to 
participate, particularly by patients who had seen an interview being tape-recorded. Of 
1.963 people who were approached to take part in the study, 388 (19.8%) acknowledged 
being smokers, and 201 agreed to participate.
Statistical power was lower than expected because actual effect size and variance 
differed from original estimates. The preliminary nature of this study necessitated 
estimating effect size and variance to determine the number of subjects required for the 
study to have adequate statistical power. Actual effect size was smaller and variance 
much greater than expected, which lowered statistical power.
Suggestions for Future Research
In spite of discouraging results for the present study, these findings should not 
lead to the conclusion that MI is not effective for helping smokers who have low 
motivation for change. Only a small effect was anticipated for MI in this study because of 
its low dose and intensity. Any effect that occurred is likely to have been offset by other 
limiting factors as discussed above, including physician counseling during the study, 
participant characteristics, demand effects, experimenter effects, non-standard treatment 
delivery conditions, and lower-than-expected statistical power. One contribution of this 
study may be uncovering these limiting factors and their possible impacts.
In future research, interventions should be delivered as an integral part of 
participants’ primary care visits. More information should be gathered to track physician 
advising during the study and to further explore participants’ health concerns. Several
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experimenters should deliver the interventions. Optimal dosage could be explored by 
comparing one-time interventions in primary care with similar interventions to which 
self-help booklets or telephone follow-up are added. Effect size and variance data from 
this study may enhance the accuracy of power analyses for similar studies in the future.
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SUMMARY AND CONCLUSIONS 
Results of the present study did not support MI as a more effective intervention 
compared to DA and CC for male smokers in the PC and C stages of change who were 
primary care patients at an urban VA medical center. However, other factors such as 
physician advising, participant characteristics, limited dose and intensity of the 
intervention, experimenter effects, environmental factors affecting treatment delivery, and 
lower-than-expected statistical power may have counteracted intervention effects.
Results of the study did indicate, however, that contemplators reported more cutting 
down and 24-hour quit attempts than pre-contemplators at three month follow up. Greater 
quitting-related activity among contemplators than among pre-contemplators supports the 
SOC theory of Prochaska & DiClemente (1983).
Because MI has been shown to be effective in other circumstances (Miller & 
Rollnick, 1991; Prochaska, et al., 1992), determining its usefulness for veterans who are 
unmotivated to quit smoking remains a worthwhile objective. Veterans are more likely 
than non-veterans to smoke, and, for those who do smoke, to smoke more heavily 
(Feigelman, 1994). The health costs of their smoking behavior are high, as are the health 
benefits of quitting for smokers of all ages (USDHHS, 1988;1989). Primary care 
providers at VA hospitals are making smoking cessation counseling a priority. Further 
research incorporating methodological and procedural lessons from this preliminary study 
could help determine whether MI might increase the effectiveness of their counseling for 
smokers in the early stages of change.
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APPENDIX A
MENU OF STAGE-MATCHED QUESTIONS AND STRATEGIES
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MENU OF STAGE-MATCHED QUESTIONS AND STRATEGIES 
Part I: Develop Rapport and Elicit General Information.
1. A typical day.
— "Where does smoking fit in?"
2. Health and smoking.
— "How do you believe smoking affects your health?"
Part II: Help Smoker Identify Problems and Solutions.
3. Elicit self-motivational statements.
A. For smokers with low Motivation scores:*
"Why did you indicate that you [want to quit smoking [ ___ (level
indicated) rather th an  (a lower level)?"
(Response provides smoker's reasons for quitting.)
— "What would need to happen for you to go from (level indicated) to
 (a higher level):"
(Response identifies solutions that are relevant to the smoker.)
B. All others:
"Why did you indicate that you are  (level indicated) sure
rather than   (a lower level) sure that you could [quit|?"
(Response highlights smokers skills for cutting down/quitting.)
— "What would need to happen for you to go from  (level
indicated)
to  (a higher level):"
(Response identifies solutions that are relevant to the smoker.)
4. Strategies
A. For smokers with low Motivation scores:
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"What are the good things about smoking?" What are the less good 
things?" "Where does that leave you?"
"Would information about the risks involved help you in your 
decision about smoking?"
B. For smokers who are concerned about smoking:
"How would you like the future to be different from the present?" 
"What concerns do you have about your smoking?"
"What are some things you can do?
" What will you do?"
Part III. Reinforce Gains Or Leave Topic Open For Further Consideration.





♦Questions and strategies for smokers with low Motivation scores (A) may be 
used with most smokers; those for others (B) are generally suitable for smokers who are 
at least entertaining the possibility of quitting.









Home Phone: (______) _______ -__________________________
Best time to call:_____________________AM PM
Your Primary Care Provider's nam e:_____________________
Highest year of school com pleted________________________
1. Do you smoke now, or have you smoked in the last month?
 Yes
No
2. Approximately how many cigarettes per day do you usually smoke?
3. At what age did you begin smoking?_____________
4. How old are you now ?____________
5. Approximately how many cigarettes per day did you usually smoke one year
ago?_____________
6. Are you seriously thinking of cutting down the number of cigarettes you smoke?
 Yes
No
7. At present, how much do you want to cut down the number of cigarettes you 
smoke?




8. If you wanted to cut down now, how sure are you that you would be able to 
do it?
 Not at all sure
 A little sure
 Somewhat sure
 Very sure
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9. How determined are you to cut down?
 Not at all determined
 A little determined
 Somewhat determined
 Very determined




11. In the last year, did you ever on purpose quit smoking for at least 24 hours?
 Yes
No
12. Are you seriously thinking about quitting smoking?
 Yes
 No
13. How much do you want to quit smoking?




14. If you decided to quit smoking completely, how sure are you that you would 
be able to do it?
 Not at all sure
 A little sure
 Somewhat sure
 Very sure
15. Do you plan to quit smoking?
 Yes
No
16 If you plan to quit smoking, by when do you plan to quit?
  1 month
 3 months
 6 months
 More than 6 months
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17. If you plan to quit smoking, how determined are you to quit?
 Not at all determined
 A little determined
 Somewhat determined
 Very determined
18. Please check off any of the following diseases that you have, or think you might
have.
  Emphysema (a lung disease)
  Chronic Obstructive Pulmonary Disease (COPD; a lung disease)
 Chronic bronchitis (a lung disease)
  Asthma (a lung disease)
  Congestive Heart Failure (CHF; a heart disease)
  Heart Attack
  Angina (Heart Pain)
  Hypertension (High Blood Pressure)
  Stroke
 Coronary Heart Disease (CHD)
  Peripheral Vascular Disease (PVD; "bad circulation")
  Cancer (Any type)
  Diabetes ("bad" blood sugar)
 O ther___________________________________________
Do not write below this line (for office use only)
MD _____________________________  MOT I ______________
FTND ___________________________  C O N F _____________
PYRS____________________________  ACD ___________ CD
STAGE___________________________ AQ ________________
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CONTEMPLATION LADDER
Each rung on this ladder represents where 
various smokers are in their thinking about 
quitting. Circle the number that indicates 




~h Taking action to quit 
^  (e.g., cutting down, 
enrolling in a program).
Starting to think about how 
to change my smoking 
patterns.
Think I should quit but 
not quite ready.
Think I need to consider 
quitting someday.
No thought of quitting.
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FTND
Please circle the one answer that best describes your smoking.
There are no right or wrong answers, so just answer as honestly as possible.
How soon after you wake up do you 
smoke your first cigarette?




2. Do you find it difficult to refrain 
from smoking in places where it is 
forbidden, for example, in church, 
at the library, in the cinema, etc.?
Yes
No
3. Which cigarette would you hate most 
to give up?
The first one in 
the morning 
All the others
4. How many cigarettes per day do you smoke? 10 or less 
11-20 
21-30 
3 1 or more
Do you smoke more frequently 
during the first hours after waking 
than during the rest of the day?
Yes
No
Do you smoke if you are so ill 
that you are in bed most o f the day?
Yes
No
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APPENDIX E 
FEEDBACK FORM FOR SMOKERS
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FEEDBACK FORM FOR SMOKERS
Did your doctor talk with you about smoking?  Yes  No
Did your doctor advise you to quit smoking?  Yes  No
Did your doctor offer help with quitting? (Some
examples of help are booklets about how to quit
smoking, information about groups for smokers
who want to quit, and prescriptions for nicotine
patches or gum or Zyban.)  Yes  No
How satisfied are you with what your doctor said about smoking? Please circle one 
number.
1 2 3 4 5 6 7
Not at all Completely
satisfied satisfied
How satisfied are you with your talk with Ms. Collicott? Please circle one number.
1 2 3 4 5 6 7
Not at all Completely
satisfied satisfied
During your meeting with Ms. Collicott, did you feel that she directly told you what to do 
about your smoking or just gave you some "food for thought"? (Choose one.)
 Told me what to do
  Gave me "food for thought"
  Neither
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APPENDIX F 
VA RESEARCH CONSENT FORM
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VA RESEARCH CONSENT FORM
Subject nam e:__________________________________________  D ate:______
Title of Study: Treating Smokers in Primary Care Settings 
Principal Investigator Neil Bien, Ph.D.
I ,________________________________________ , a patient w ith__________________
Have been asked by Ms. Collicott to take part in this research project.
PURPOSE OF STUDY
The purpose of this study is to help health care providers learn what smokers think 
About smoking and how health care providers can best help them.
PROCEDURES
This is a research study in which I will be asked to fill out three short questionnaires 
about smoking and to talk briefly with Ms. Collicott. This will take approximately 25 
minutes while I am waiting to see my doctor. (1 will NOT lose my turn to be seen by my 
doctor.) I will also be asked to complete one brief form after seeing my doctor. During the 
next year, I may or may not receive up to five telephone calls asking me to answer 
approximately 20 brief questions from the questionnaires I complete today. If I receive 
calls, they will be approximately one, three, six, and 12 months from today. Each phone 
call should take approximately five minutes. After the last phone call, Ms. Collicott will 
send me a letter telling me more about the purpose o f this study, how it was performed, 
and what results are expected from i t
DISCOMFORT OR INCONVENIENCE
No discomfort is expected from taking part in this study. Any inconvenience is 
expected to be minor.
POSSIBLE RISKS
No risks are expected from taking part in this study.
POSSIBLE BENEFITS
My participation may help health care providers learn what smokers think about 
smoking and how health care providers can help them, whether or not the smokers want 
to quit.
COSTS/COMPENSATION
The only cost of participating will be the time I spend answering questions and 
taking part in the interview. I will not be paid for taking part in this study.
Subject’s Initials__________
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CONFIDENTIALITY
All information I provide will be kept confidential. It will only be used for this study 
and will not be given to anyone else. My name will not be used in any reports or 
publications resulting from the study. My information will be kept in a locked file and 
destroyed when the study is complete.
SPECIAL CIRCUMSTANCES
If my doctor feels that it is in my best interest to withdraw me from the study, he/she 
will do so immediately. I will be told of any findings from the study which may cause me 
to change my mind about staying in the study. In case there are medical problems or 
questions, I have been told I can call Ms. Collicott at (410) 642-2411, extension 5390.
RESEARCH SUBJECTS’ RIGHTS
I have read or have had read to me all of the above. Ms. Collicott has explained the 
study to me and answered all of my questions. I have been told o f the risks or discomforts 
and possible benefits of the study.
I understand that I do not have to take part in this study, and my refusal to participate 
will involve no penalty or loss o f my rights to which I am entided. I may withdraw from 
this study at any dme without penalty or loss of VA or other benefits to which I am 
entitled.
I understand that any information about me taken for this study will be kept strictly 
confidential. I do understand that my records may be subpoenaed by court order or may 
be inspected by federal regulatory authorities.
I understand my rights as a research participant, and I voluntarily consent to 
participate in this study. I understand what the study is about and how and why it is being 
done. I will receive a signed copy of this consent form.
If I have any questions regarding my rights as a patient in this study, I may contact 
Dr. Richard Levine, the Chief o f Research at this hospital at (202) 745-8478.
Signature__________________________________  Date______________
W itness____________________________________  Witness (P rin t)__________________
My initials here show that I have received a copy of this consent form
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
79
Page 3 of 3
I, Sheila Collicott, certify that I have explained to the above subject the nature and 
purpose of the study, and potential benefits and possible risks associated with 
participation in this study. I have answered any questions that have been raised and have 
witnessed the above signature. I have explained the above to the subject on the date stated 
on this consent form.
Signature_________________________________  Date_______________
Washington VA Medical Center
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DEBRIEFING FORM 
Thank you for taking part in this study. Your participation helps us learn more about 
what smokers think about smoking and how health care providers can be helpful to them.
You may receive several brief telephone calls from us within the next year. We 
would greatly appreciate your continued participation because, without it, our efforts to 
learn how to better help smokers will be impaired.
If you would like to receive the results of this study, please write your name and 
address in the space below and return that part of this page to the experimenter. It may be 
one to two years before results are available, so please be patient Again, thank you for 
your participation.
Please send results of this study to:
N am e:________________________
A ddress:______________________
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INTERVIEW RATING FORM
Please listen to the taped interviews and check the characteristics that best 
describe what the interviewer does.
A. Tells the smoker direcdy that he 
should quit smoking
B. Asks the smoker to describe what 
smoking is like for him
C. Focuses the conversation on health 
related topics other than smoking
D. Describes the health consequences 
of smoking
E. Asks the smoker what he thinks would help 
him be more motivated/confident/ready to quit
F. Describes quitting techniques
G. Listens, reflects back, and summarizes 
what the smoker has said
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RATER INSTRUCTIONS 
Check all the characteristics that are most descriptive of the interviewer’s actions in each 
interview.
Check A if the interviewer tells the smoker directly to qu it
Check B if she asks about his personal experience of smoking, including the part 
it plays in his life and what he thinks or feels about his smoking.
Check C if the conversation is about health behaviors, but not smoking.
Check D if the interviewer provides the smoker with information about how 
smoking affects health, either his or others.
Check E if she asks the smoker about factors affecting his motivation, confidence, 
and readiness to quit and how he might increase his motivation, confidence, and/or 
readiness.
Check F if she describes techniques the smoker could use to qu it
Check G if she listens, re-states what the smoker tells her, and summarizes each 
part of the interview before moving on to the next
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VITA
Sheila Collicott was bom in Scott City Kansas in March, 1950. She graduated 
from the Gemological Institute of America in 1976 and was employed as a gemologist in 
California, Colorado, and Virginia. After volunteer work with Sierra II, a wilderness- 
based alternative probation program for adolescents in Virginia Beach, Virginia, she 
earned a B.A. in psychology, graduating Summa Cum Laude from St. Mary’s College of 
Maryland in 1991. In 1992 she entered the Virginia Consortium Program in Clinical 
Psychology, 287 Independence Boulevard, Suite 301, Virginia Beach, Virginia 23462. 
During the program, she gained clinical experience at a variety of sites, including Eastern 
Virginia State Hospital and the Counseling Center at The College of William and Mary. 
Her area of concentration was brief therapy. She completed her clinical internship at 
Perry Point VA Medical Center. Perry Point, MD, where she focused on geriatrics and 
behavioral medicine.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
